Yasheng Li

Prof. Yasheng Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
ZZZhao-Sheng Zhang
Zhao-Sheng Zhang
ZHZhe He
Zhe He
YSYu Shi
Yu Shi
MGMingming Guan
Mingming Guan
DZDong-Sheng Zhao
Dong-Sheng Zhao
ZCZining Cui
Zining Cui

12 May 2023 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZYZhikun Yang
Zhikun Yang
YCYue Cai
Yue Cai
SMShen Mao
Shen Mao
QWQihao Wu
Qihao Wu
MZMengdi Zhu
Mengdi Zhu
Hong WangHong Wang
Hong Wang

27 February 2025 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
ZZZhao-Sheng Zhang
Zhao-Sheng Zhang
DZDong-Sheng Zhao
Dong-Sheng Zhao
DZDi Zhu
Di Zhu
MGMingming Guan
Mingming Guan
LXLan-Tu Xiong
Lan-Tu Xiong
ZCZining Cui
Zining Cui

11 July 2024 in Chemical Engineering Journal
Verified
Journal Article
Closed access
JYJing Yang
Jing Yang
YYYi Yang
Yi Yang
SZShijie Zeng
Shijie Zeng
YJYueyue Jiang
Yueyue Jiang
CGChunwen Guo
Chunwen Guo
XXXu Xiang
Xu Xiang

9 October 2024 in ACS Infectious Diseases
Verified
Journal Article
Open access
QLQingqing Li
Qingqing Li
PTPing Tian
Ping Tian
MGMingjuan Guo
Mingjuan Guo
XLXiaoqiang Liu
Xiaoqiang Liu
TSTingting Su
Tingting Su
JLJiabin li
Jiabin li
Methicillin-resistant Staphylococcus aureus (MRSA) is a major human pathogen that causes various diseases. Extensive researches highlight the significant role of gut microbiota and its metabolites, particularly spermidine, in infectious diseases. However, the immunomodulatory mechanisms of spermidine in MRSA-induced bloodstream infection remain unclear. Here, we confirmed the protective effects of spermidine in bloodstream infection in mice. Spermidine reduced the bacterial load and expression of inflammatory factors by shifting the macrophage phenotype to an anti-inflammatory phenotype, ultimately prolonging the survival of the infected mice. The protective effect against MRSA infection may rely on the elevated expression of protein tyrosine phosphatase nonreceptor 2 (PTPN2). Collectively, these findings confirm the immunoprotective effects of spermidine via binding to PTPN2 in MRSA bloodstream infection, providing new ideas for the treatment of related infectious diseases.

7 February 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YYYi Yang
Yi Yang
GYGuang-Wei Yang
Guang-Wei Yang
JLJian-Juan Lu
Jian-Juan Lu
HCHao-Ran Chen
Hao-Ran Chen
YGYa-Qin Guo
Ya-Qin Guo
JLJiabin li
Jiabin li
Bacterial cystitis, a commonly occurring urinary tract infection (UTI), is renowned for its extensive prevalence and tendency to recur. Despite the extensive utilization of levofloxacin as a conventional therapeutic approach for bacterial cystitis, its effectiveness is impeded by adverse toxic effects, drug resistance concerns, and its influence on the gut microbiota. This study introduces Lev@PADM, a hydrogel with antibacterial properties that demonstrates efficacy in the treatment of bacterial cystitis. Lev@PADM is produced by combining levofloxacin with decellularized porcine acellular dermal matrix hydrogel and exhibits remarkable biocompatibility. Lev@PADM demonstrates excellent stability as a hydrogel at body temperature, enabling direct administration to the site of infection through intravesical injection. This localized delivery route circumvents the systemic circulation of levofloxacin, resulting in a swift and substantial elevation of the antimicrobial agent’s concentration specifically at the site of infection. The in vivo experimental findings provide evidence that Lev@PADM effectively prolongs the duration of levofloxacin’s action, impedes the retention and invasion of E.coli in the urinary tract, diminishes the infiltration of innate immune cells into infected tissues, and simultaneously preserves the composition of the intestinal microbiota. These results indicate that, in comparison to the exclusive administration of levofloxacin, Lev@PADM offers notable benefits in terms of preserving the integrity of the bladder epithelial barrier and suppressing the recurrence of urinary tract infections. Graphical Abstract